OpenVSafe by OpenVAERS
Search V-safe

ZXE-33280-75576

2 vaccinations 2 coded responses 3 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
626 / IL
Registered
2021-03-14
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-04
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-14
    Registered in v-safe
  3. 2021-03-14
    Survey response — day 7, dose 1
    MedDRA: Unevaluable event — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: Had strong symptoms for 3 days after dose 1. Mostly late afternoon-night. Felt fine morning/early afternoon.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-03-24
    Dose 2 — Pfizer-BioNTech
  5. 2021-03-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  6. 2021-06-23
    Survey response — 3 months, dose 2
    MedDRA: Pregnancy — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Pregnant
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-06-23
    Report sent to call center — 3 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  8. 2021-06-25

Vaccinations

DoseDateManufacturerCo-administered
12021-03-04Pfizer-BioNTech
22021-03-24Pfizer-BioNTech

Call center

ReportedOutcomeVAERS-related outcome
2021-06-23 Unsuccessful

Free text

Release 5 — day 7, dose 1

2021-03-14

Systemic reaction (other): Had strong symptoms for 3 days after dose 1. Mostly late afternoon-night. Felt fine morning/early afternoon.

Release 9 — 3 months, dose 2

2021-06-23

Symptoms: Pregnant

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDPregnancy ✓ ✓ ✓
SROUnevaluable event ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release